Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotime-Nasdaq's best kept secret? -- Ignore unavailable to you. Want to Upgrade?

To: tuck who wrote (1334)	6/22/1999 10:22:00 AM
From: Jim Roof	Read Replies (1) \| Respond to of 1432

Tuck, Next qtr's sales figures will undoubtedly be entered as exhibit A in the short's case against BTIM. Seeing as how the product will have just hit the street and the pipeline just opened for consumption there is no doubt in my mind that sales will be weak. Now, let me remind you that I am long and I am not expecting much at all in the quarter in which rollout begins. Who in their right mind would look for 0-300 mph acceleration in .1 seconds? It will take a while for an accurate gauge to develop on Hextend's actual sales but that will not stop the shorts from heralding triumph when the first sales figures are out. At this point in time I think nobody has any real solid idea on the topic. Jim